These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8313613)

  • 1. Neuropeptides and anxiety: focus on cholecystokinin.
    Lydiard RB
    Clin Chem; 1994 Feb; 40(2):315-8. PubMed ID: 8313613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two faces of cholecystokinin: anxiety and schizophrenia.
    Bourin M; Malinge M; Vasar E; Bradwejn J
    Fundam Clin Pharmacol; 1996; 10(2):116-26. PubMed ID: 8737954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular and functional characterization of cionin receptors in the ascidian, Ciona intestinalis: the evolutionary origin of the vertebrate cholecystokinin/gastrin family.
    Sekiguchi T; Ogasawara M; Satake H
    J Endocrinol; 2012 Apr; 213(1):99-106. PubMed ID: 22289502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin and learning and memory processes.
    Hadjiivanova C; Belcheva S; Belcheva I
    Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the significance of cholecystokinin receptors in panic disorder.
    van Megen HJ; den Boer JA; Westenberg HG
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin in psychiatric research: a time for cautious excitement.
    Abelson JL
    J Psychiatr Res; 1995; 29(5):389-96. PubMed ID: 8748063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin and panic disorder--three unsettled questions.
    Rehfeld JF
    Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes.
    Botella A; Delvaux M; Berry P; Frexinos J; Bueno L
    Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK antagonists: pharmacology and therapeutic interest.
    Wettstein JG; Buéno L; Junien JL
    Pharmacol Ther; 1994; 62(3):267-82. PubMed ID: 7972336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK in anxiety and cognitive processes.
    Daugé V; Léna I
    Neurosci Biobehav Rev; 1998 Oct; 22(6):815-25. PubMed ID: 9809313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cholecystokinin in the induction of aggressive behavior: a focus on the available experimental data (review).
    Katsouni E; Zarros A; Skandali N; Tsakiris S; Lappas D
    Acta Physiol Hung; 2013 Dec; 100(4):361-77. PubMed ID: 24317345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA; Blanchard JC
    Therapie; 1992 Nov; 47(6):541-8. PubMed ID: 1301646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.